Cameron Snell - Concepedia

Author

Cameron Snell

Also Known As

C Snell, C. Snell, Cameron E Snell, Cameron E. Snell, Cameron E. Snell (522607), Cameron Edward Snell, Cameron Snell, Cameron E. Snell, Snell, Cameron, Snell, Cameron E.

197

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Queensland Mater Research University of Oxford Translational Research Institute Mater Health Services

About

Cameron Snell is an author at The University of Queensland specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1.8K
2	Biochemistry	3	3	620
3	Engineering	2	2	325
4	Natural Sciences	1	1	100
5	Biomedical Engineering	1	1	15

Cameron Snell

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Glucose Utilization via Glycogen Phosphorylase Sustains Proliferation and Prevents Premature Senescence in Cancer Cells Elena Favaro, Karim Bensaad, Mei Chong, Cell Metabolism Tumor BiologyPrevents Premature SenescenceBiochemistryGlycosylationDiabetes	2012	398
microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer Francesca M. Buffa, Laura Winchester, Cameron Snell, Cancer Research Breast OncologyEngineeringPathologyGene Expression ProfilingTumor Biology	2011	310
A Core Human Primary Tumor Angiogenesis Signature Identifies the Endothelial Orphan Receptor ELTD1 as a Key Regulator of Angiogenesis Massimo Masiero, Filipa C. Simões, Hee Dong Han, Cancer Cell AngiogenesisKey RegulatorMedicineTumor GrowthCancer Growth	2013	306
Carbonic Anhydrase IX Promotes Tumor Growth and Necrosis <i>In Vivo</i> and Inhibition Enhances Anti-VEGF Therapy Alan McIntyre, Shalini Patiar, Simon Wigfield, Clinical Cancer Research	2012	234
DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy <i>In Vivo</i> Jiliang Li, Richard C.A. Sainson, Chern Ein Oon, Cancer Research ImmunologyCancer BiologyGliomaTumor BiologyAngiogenesis	2011	223
BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1tumour phenotype Cameron Snell, Michael Krypuy, Ee Ming Wong Breast Cancer Research	2008	163
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer Simon Lord, Wei-Chen Cheng, Dan Liu, Cell Metabolism Breast OncologyPathologyMetabolic Adaption PathwaysMetabolic RemodelingTumor Biology	2018	122
Disrupting Hypoxia-Induced Bicarbonate Transport Acidifies Tumor Cells and Suppresses Tumor Growth Alan McIntyre, Alžbeta Hulı́ková, Ioanna Ledaki, Cancer Research Cancer BiologyTumor BiologyOxidative StressSuppresses Tumor GrowthSlc4a9 Disruption	2016	100
Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer Mark N. Adams, Joshua T. Burgess, Yaowu He, Journal of Thoracic Oncology Potential Therapeutic TargetMedicinePathologyCancer Cell BiologyCancer Genomics	2017	84
Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination Ben Emery, Holly S. Cate, Mark Marriott, Proceedings of the National Academy of Sciences ImmunologyCell DeathImmunologic MechanismImmunotherapyNeuroinflammation	2006	75

Page 1